To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Aortic Stent Grafts Market size was valued at USD 3.35 Billion in 2024 and is poised to grow from USD 3.51 Billion in 2025 to USD 5.06 Billion by 2033, growing at a CAGR of 4.7% during the forecast period (2026–2033). 

    The competitive landscape for the global aortic stent grafts market is fragmented owing to the presence of multiple vendors. Most players are making heavy investments on R&D, and new market initiatives to gain a competitive edge and attract high revenues. Other vendors are focusing on increasing their global presence, production sites and facilities, production capacities, company strengths and weaknesses, and on new product launches to ensure their brand name stays amongst the top competitors. 'Medtronic (Ireland) ', 'W. L. Gore & Associates, Inc. (USA) ', 'Cook Medical (USA) ', 'Terumo Aortic (Japan) ', 'Endologix LLC (USA) ', 'Jotec (Germany) ', 'MicroPort Scientific Corporation (China) ', 'Corcym (Italy) ', 'Edwards Lifesciences Corporation (USA) ', 'Bentley Healthcare Pvt. Ltd. (India) ', 'Braile Biomédica (Brazil) ', 'Cardinal Health (USA) ', 'InSitu Technologies Inc. (USA) ', 'Artivion Inc. (USA) ', 'Cryolife Inc. (USA) ', 'Lombard Medical Inc. (UK) ', 'Bolton Medical (Spain)'

    The market for aortic stent grafts is anticipated to grow during the forecast period due to factors such as the adoption of endovascular repair over open surgical repair, growing life expectancy rate, the increasing use of minimally invasive surgeries, surge in number of clinical trials, and FDA approvals for the development of better aortic stent graft designs.

    The market for aortic aneurysm stent grafts is anticipated to grow rapidly as a result of an ageing population and an increase in patients with aortic aneurysms, increased regulatory approvals, and quickening technological development efforts. The market will expand from 2023 to 2030 due to a rise in the prevalence of cardiac disorders and rising consumer awareness of stents and graph devices.

    The market for aortic aneurysm stent grafts is anticipated to be dominated by North America. This is attributable to the rising aortic aneurysm cases, technological improvements, and robust financial incentives in the United States and Canada. Additionally, the increasing use of aortic aneurysm stent grafts in the nation will increase demand for therapies that incorporate them, thus, fostering a favourable environment for the expansion of the North American aortic aneurysm stent graft market.

    Feedback From Our Clients

    Global Aortic Stent Grafts Market

    Report ID: SQMIG35B2078

    $5,300
    BUY NOW